We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
-27.1%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
AUM
$1.38B
AUM Growth
+$1.02B
Cap. Flow
+$1.29B
Cap. Flow %
93.55%
Top 10 Hldgs %
92.32%
Holding
28
New
3
Increased
8
Reduced
Closed
2

Similar funds

Finepoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Finepoint Capital held 28 positions worth $1.38B, up 291% from $352M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Finepoint Capital deployed $1.29B of net new capital in Q3 2024, opening 3 new positions and adding to 8 existing holdings. Its largest new stake was QXO Inc: 25,750,781 shares worth $406M.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, followed by Healthcare and Communication Services.

On the sell side, the most notable exit was Churchill Capital Corp VII Warrants, an estimated $192K sold.

  • Finepoint Capital's largest Q3 2024 buy was QXO Inc: 25,750,781 shares worth $406M.
  • Finepoint Capital added most to SpringWorks Therapeutics in Q3 2024, an estimated $467K increase.
  • Finepoint Capital fully exited Churchill Capital Corp VII Warrants in Q3 2024, selling an estimated $192K.
  • Finepoint Capital's ten largest holdings make up 92% of its $1.38B portfolio in Q3 2024.
  • Finepoint Capital opened 3 new positions and closed 2 in Q3 2024.
  • Finepoint Capital's portfolio value rose 291% quarter-over-quarter to $1.38B.

Based on Finepoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.